In Early-Chronic Phase Chronic Myeloid Leukemia Patients Treated with Imatinib, Resistance Is Rarely Mediated by Abl Kinase Domain Mutations.
暂无分享，去创建一个
M. Baccarani | G. Rosti | G. Martinelli | I. Iacobucci | S. Soverini | M. Breccia | G. Specchia | F. Castagnetti | E. Abruzzese | M. Amabile | S. Merante | F. Radaelli | A. Gnani | F. Palandri | A. Poerio | A. Capucci | Sabrina Colarossi